MARIZYME, INC.
company.status.inactiveCIK 1413754fmd_1YFDV8MBTPQ58N5RZ2FAH3EFNAManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2024, 52 periods
| Line item | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | – | 0 | 0 | 0 |
| Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | – | 0 | 0 | 0 |
| Provision for credit losses | 2 | 2 | 0 | 0 | – | – | – | – | – | – |
| Research and development | – | – | – | – | – | – | 1 | 2 | 4 | 2 |
| Total operating expenses | 1 | 1 | 0 | 0 | 0 | 1 | 6 | 9 | 38 | 35 |
| Operating income | (1) | (1) | (0) | (0) | (0) | (1) | (6) | (9) | (37) | (34) |
| Interest expense | – | – | – | – | – | – | 0 | – | – | – |
| Interest and investment income | – | – | – | – | – | – | – | – | – | – |
| Other non-operating income (expense) | (9) | (8) | (1) | (0) | (0) | – | (0) | (2) | (1) | (35) |
| Income before taxes | – | – | – | – | – | – | – | – | – | – |
| Income tax expense | – | – | – | – | – | – | – | – | – | – |
| Net income from continuing operations | – | – | – | – | – | – | – | – | – | – |
| Net income | (10) | (9) | (1) | (1) | (0) | (1) | (6) | (11) | (38) | (70) |
| Net income to common shareholders | – | – | – | – | – | – | – | – | – | – |